Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference

_{//health-fitness.news-articles.net/content/2012/ .. at-the-jmp-securities-healthcare-conference.html}
^{Published in Health and Fitness on Monday, July 9th 2012 at 5:43 GMT by Market Wire}  

Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference -- SAN DIEGO, July 9, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about OREX

SAN DIEGO, July 9, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: [ OREX ]) today announced that management will present a company overview at the JMP Securities Healthcare Conference in New York. The presentation is scheduled for Thursday, July 12th at 3:00 p.m. EDT. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at [ www.orexigen.com ]. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at [ www.orexigen.com ].

SOURCE Orexigen Therapeutics, Inc.

RELATED LINKS
[ http://www.orexigen.com ]